Keratinocyte_growth_factor_precursor
Category
Keratinocyte_growth_factor_precursor Brand names, Keratinocyte_growth_factor_precursor Analogs
Keratinocyte_growth_factor_precursor Brand Names Mixture
No information avaliable
Keratinocyte_growth_factor_precursor Chemical_Formula
C721H1142N202O204S9
Keratinocyte_growth_factor_precursor RX_link
No information avaliable
Keratinocyte_growth_factor_precursor fda sheet
Keratinocyte_growth_factor_precursor msds (material safety sheet)
Keratinocyte_growth_factor_precursor Synthesis Reference
No information avaliable
Keratinocyte_growth_factor_precursor Molecular Weight
16192.7
Keratinocyte_growth_factor_precursor Melting Point
No information avaliable
Keratinocyte_growth_factor_precursor H2O Solubility
No information avaliable
Keratinocyte_growth_factor_precursor State
Liquid
Keratinocyte_growth_factor_precursor LogP
-0.650
Keratinocyte_growth_factor_precursor Dosage Forms
Solution (IV Injection)
Keratinocyte_growth_factor_precursor Indication
For treatment of mucositis (mouth sores)
Keratinocyte_growth_factor_precursor Pharmacology
Used in the prevention or treatment of oral mucoscitis (mouth ulcers arising from chemotherapy), Kepivance binds to the human keratinocyte growth factor (KGF) receptor on buccal cell surfaces. Kepivance acts as both a cell growth and survival factor by stimulating epithelial cell proliferation, differentiation, and migration around the tongue and mouth. The KGF receptor is found on many tissues particularly around the tongue, esophagus, salivary gland and other gastro-intestinal tract organs.
Keratinocyte_growth_factor_precursor Absorption
No information avaliable
Keratinocyte_growth_factor_precursor Toxicity
No information avaliable
Keratinocyte_growth_factor_precursor Patient Information
No information avaliable
Keratinocyte_growth_factor_precursor Organisms Affected
Humans and other mammals
